Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Edgewise Therapeutics (EWTX) Other Gross PP&E Adjustments (2020 - 2026)

Edgewise Therapeutics has reported Other Gross PP&E Adjustments over the past 7 years, most recently at $13.4 million for Q1 2026.

  • Quarterly results put Other Gross PP&E Adjustments at $13.4 million for Q1 2026, up 5.59% from a year ago — trailing twelve months through Mar 2026 was $13.4 million (up 5.59% YoY), and the annual figure for FY2025 was $6.8 million, down 11.95%.
  • Other Gross PP&E Adjustments reached $13.4 million in Q1 2026 per EWTX's latest filing, up from $6.8 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $13.4 million in Q1 2026 and bottomed at $94000.0 in Q1 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was $10.2 million (2023), compared with a mean of $8.8 million.
  • The largest annual shift saw Other Gross PP&E Adjustments plummeted 90.67% in 2022 before it surged 9757.45% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at $5.9 million in 2022, then grew by 14.31% to $6.7 million in 2023, then grew by 14.91% to $7.7 million in 2024, then dropped by 11.95% to $6.8 million in 2025, then surged by 97.43% to $13.4 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for EWTX at $13.4 million in Q1 2026, $6.8 million in Q4 2025, and $12.9 million in Q3 2025.